C07B 59/001
Acyclic or carbocyclic compounds
Official title: {Acyclic or carbocyclic compounds}
C07B59/001 (Acyclic or carbocyclic compounds) appears on 431 US grants and 724 published applications in this corpus.
Search patents in C07B- Granted patents
- 431
- Published applications
- 724
- Assignees
- 359
- Inventors
- 1,622
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 8 | 0 |
| 1995 | 7 | 0 |
| 1996 | 10 | 0 |
| 1997 | 3 | 0 |
| 1998 | 8 | 0 |
| 1999 | 3 | 0 |
| 2000 | 5 | 0 |
| 2001 | 5 | 1 |
| 2002 | 2 | 5 |
| 2003 | 2 | 2 |
| 2004 | 4 | 2 |
| 2005 | 0 | 7 |
| 2006 | 3 | 13 |
| 2007 | 1 | 13 |
| 2008 | 5 | 23 |
| 2009 | 5 | 45 |
| 2010 | 9 | 30 |
| 2011 | 12 | 30 |
| 2012 | 18 | 22 |
| 2013 | 17 | 32 |
| 2014 | 20 | 42 |
| 2015 | 24 | 33 |
| 2016 | 25 | 36 |
| 2017 | 22 | 26 |
| 2018 | 22 | 31 |
| 2019 | 34 | 37 |
| 2020 | 30 | 29 |
| 2021 | 19 | 40 |
| 2022 | 28 | 50 |
| 2023 | 12 | 47 |
| 2024 | 21 | 41 |
| 2025 | 16 | 44 |
| 2026 | 20 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Selective transition metal catalyzed deuterium incorporation into alkyne and alkene functionalities15 Sep 2026US 12,735,369 B2Marquette University
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Deuterated compounds for electronic applications30 Jun 2026US RE50,942 E1LG Chem.Ltd.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Alkyne compound, vitamin D compound, analytical method, and production method19 May 2026US 12,630,505 B2JEOL Ltd.
- 18f-fluorinated fatty acids and uses thereof8 Oct 2026US 2026/0308102 A1Ratio Therapeutics, Inc.
- Compositions and methods for the treatment of ocular disorders8 Oct 2026US 2026/0308108 A1
- Selective Serotonin Receptor Modulators and Methods of Making and Using the Same8 Oct 2026US 2026/0308110 A1Park City Bio, LLC
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Salt form and polycrystalline form of allopregnanolone derivative, preparation method therefor, and use thereof17 Sep 2026US 2026/0274887 A1Nanjing Minova Pharmaceutical Co., Ltd.
Most cited
By later US patents
- 4-hydroxybutyric acid analogs75US 8,461,197 B2Concert Pharmaceuticals, Inc. · 2013
- Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging74US 6,019,957 AThe University of Tennessee Research Corporation · 2000
- 4-hydroxybutyric acid analogs72US 8,759,394 B2Concert Pharmaceuticals, Inc. · 2014
- High affinity tamoxifen derivatives and uses thereof71US 5,192,525 ABoard of Regents, The University of Texas System · 1993
- Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition71US 6,168,776 AUniversity of Pittsburgh · 2001